Tectonic Therapeutic | AVRO - Selling And Administration Expenses

Stock Price
27.89
Daily Change
-1.91 -6.41%
Monthly
-6.03%
Yearly
32.87%
Q2 Forecast
28.40

Tectonic Therapeutic reported $3.44M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alnylam Pharmaceuticals USD 282.51M 2.55M Mar/2026
Celltrion KRW 12.71B 237.27B Dec/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.45B 326M Mar/2026
Ionis Pharmaceuticals USD 151M 21M Mar/2026
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Karyopharm Therapeutics USD 9.56M 17.63M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
MacroGenics USD 7.94M 1.96M Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Ovoca Bio EUR 632K 2.33M Jun/2025
Pfizer USD 2.92B 1.16B Mar/2026
Pharma Mar EUR 15.31M 2M Mar/2026
Qiagen NV USD 153.88M 10.77M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sanofi EUR 2.33B 419M Mar/2026
Sarepta Therapeutics USD 54.03M 51.35M Mar/2026
Sartorius EUR 221.3M 500K Mar/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Takeda JPY 292B 9.21B Mar/2026
Tilray USD 24.85M 1.7M Sep/2025
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026